Overview

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
0
Participant gender:
All
Summary
Comparing induction chemotherapy followed by cisplatin chrono-chemotherapy concurrent combined with intensity-modulated radiation therapy (chrono-chemotherapy group) with induction chemotherapy followed by cisplatin routine-chemotherapy concurrent combined with intensity-modulated radiation therapy (routine-chemotherapy group) in the treatment of locally advanced nasopharyngeal carcinoma, observing the adverse reaction and effects of two groups,expected chrono-chemotherapy group can achieve lower toxicity, improve the curative effect, for the treatment of nasopharyngeal carcinoma provides a more reasonable way.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Feng Jing
Treatments:
Cisplatin
Criteria
Inclusion Criteria:

1. Pathological diagnosis of early cure Ⅲ - Ⅳ stage of patients with advanced
nasopharyngeal carcinoma (according to the 2010 UICC staging criteria, T3-4, N0-3), no
evidence of distant metastasis (M0). A measurable tumor lesions;

2. Karnofsky score≥70;

3. Age 18-70 years old, male or female;

4. No major organ dysfunction; Normal bone marrow hematopoietic function (white blood
cell ≥4.0×109/L,platelet≥100×109 /L. hemoglobin ≥100g/L),normal liver function (total
bilirubin、alanine aminotransferase、 aspartate aminotransferase ≤1.5 times the upper
limit of normal),normal renal function (creatinine ≤1.5 times the upper limit of
normal) electrocardiogram does not affect the normal treatment;

5. To understand this study and sign informed consent form.

Exclusion Criteria:

1. A distant metastasis;

2. Patients with physical or mental illness, and researchers think that patients can't
fully or adequately understand the possible complications of this study;

3. Pregnancy (confirmed by serum or urine β-HCG test) or between lactation period;

4. Serious complications, such as uncontrollable hypertension, heart function failure,
diabetes, etc.; 5.Who had received radiation and chemotherapy.